Analyst firms · Raymond James · CHRW
Raymond James CHRW price target and rating history
C.H. Robinson Worldwide Inc. (CHRW) · Industrials
Raymond James rates C.H. Robinson Worldwide Inc. (CHRW) Outperform with a $123 price target, as of its latest action on Jan 10, 2025. It has published 3 rating actions on CHRW since November 2022, including 1 upgrade and 1 downgrade. Across 6 firms with a CHRW price target in the last 12 months, the median target is $192.50.
- Current rating
- Outperform
- Price target
- $123
- Median target, all firms
- $192.50
- Actions on CHRW
- 3
Every Raymond James rating on CHRW
- Jan 10, 2025
- May 15, 2024
- Nov 15, 2022
How other firms rate CHRW
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Deutsche Bank | Hold | $153 | Oct 12, 2026 |
| Citigroup | Buy | $185 | Sep 8, 2026 |
| TD Cowen | Hold | $152 | Jul 30, 2026 |
| Citizens JMP | Mkt Perform | $235 | Jul 15, 2026 |
| Jefferies | Buy | $200 | May 20, 2026 |
| Barclays | Overweight | $200 | Dec 16, 2025 |
Questions about Raymond James and CHRW
- What is Raymond James's price target for CHRW?
- Raymond James's latest stated price target for C.H. Robinson Worldwide Inc. (CHRW) is $123, from its action on Jan 10, 2025.
- What is Raymond James's rating on CHRW?
- Raymond James rates CHRW Outperform, a bullish rating, as of Jan 10, 2025.
- When did Raymond James last change its view on CHRW?
- On Jan 10, 2025, Raymond James upgrades to Outperform from Mkt Perform, price target $123.
- How does Raymond James's CHRW target compare with other analysts?
- Across 6 firms with a CHRW price target in the last 12 months, the median target is $192.50.
More CHRW rating histories
- Citigroup9
- TD Cowen12
- Barclays5
- Wolfe Research5
- Stifel3
- Susquehanna3
- Wells Fargo3
- UBS3
- J.P. Morgan6
- BofA Securities5
- Vertical Research4
All Raymond James ratingsCHRW news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.